#StemCells Researcher | Director of the Cell Processing Facility
University of Montpellier - CHU of Montpellier | #StemCells #iPScells for #lung #CellTherapy |
Stem Genomics co-founder | President of the FSSCR
T-MAXIMUM Pharmaceutical announced that its proprietary allogeneic B7-H3–targeted CAR-T therapy, MT027, has received FDA IND clearance.
buff.ly/wiGPeyR
buff.ly/eZtS5NG
#CARTCells #Autoimmune disease
Reposted by John De Vos
Reposted by John De Vos, Gerald Friedman
Reposted by John De Vos
Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia | New England Journal of Medicine buff.ly/7jYX07o
Reposted by John De Vos
Attention, vous devez vous inscrire pour y participer.